Dentsply Sirona (XRAY) Misses Q3 EPS by 13c; Offers Guidance

Dentsply Sirona (NASDAQ: XRAY) reported Q3 EPS of $0.41, $0.13 worse than the analyst estimate of $0.54. Revenue for the quarter came in at $947 million versus the consensus estimate of $1.03 billion.

GUIDANCE:

Dentsply Sirona sees FY2022 EPS of $1.90-$2.00, versus the consensus of $1.95. Dentsply Sirona sees FY2022 revenue of $3.85-3.88 billion, versus the consensus of $3.985 billion.

For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Morgan Stanley Resumes Urban Outfitters, Inc. (URBN) at Overweight
• ArcelorMittal (MT:NA) (MT) PT Raised to EUR65 at Jefferies